Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemiparin Dose Comparison in Hospitalized COVID-19 Patients
NCT04420299Phase 2Terminated
- Sponsor
- Fundación de Investigación HM Hospitales
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bemiparin in coronavirus disease 2019 (COVID-19), sponsored by Fundación de Investigación HM Hospitales. Started Jun 2020; status: terminated.
02
Drugs
bemiparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04420299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420299.